Nu Skin Enterprises (NUS) Receivables (2009 - 2026)

Nu Skin Enterprises (NUS) has 18 years of Receivables data on file, last reported at $45.0 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 20.44% year-over-year to $45.0 million; the trailing twelve-month figure through Mar 2026 stood at $45.0 million (down 20.44% YoY), and the FY2025 full-year result was $39.5 million, down 22.13% from the prior year.
• Receivables climbed to $45.0 million in Q1 2026, from $39.5 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $77.3 million in Q3 2023 to a low of $39.5 million in Q4 2025.
• A 5-year average of $56.6 million and a median of $56.6 million in 2025 frame the typical range for Receivables.
• Across the five-year window, Receivables plunged 32.47% in 2022 and soared 60.97% in 2023, its largest moves.
• Tracing NUS's Receivables over 5 years: stood at $47.4 million in 2022, then increased by 23.93% to $58.7 million in 2023, then retreated by 13.48% to $50.8 million in 2024, then declined by 22.13% to $39.5 million in 2025, then grew by 13.83% to $45.0 million in 2026.
• Business Quant data shows NUS's Receivables at $45.0 million in Q1 2026, $39.5 million in Q4 2025, and $48.9 million in Q3 2025.